{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:29:06Z","timestamp":1766467746918,"version":"3.46.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A 55-year-old woman presented to our hospital with arthritis of the hands. Tests for anti-cyclic citrullinated peptide antibodies and rheumatic factor were negative, and seronegative rheumatoid arthritis was diagnosed. The patient was treated with methotrexate and certolizumab (tumour-necrosis factor-\u03b1 inhibitor). Disease activity was controlled with the drugs, but after 14\u00a0months, erythematous plaques with scaling appeared on the palms and feet. Skin biopsy revealed bullous lesions with aseptic abscess formation, leading to the diagnosis of palmoplantar pustulosis and pustulotic arthro-osteitis. The patient had a family history of palmoplantar pustulosis. The skin lesions improved after discontinuation of certolizumab and treatment with ointments and phototherapy. This case suggests that tumour-necrosis factor-\u03b1 inhibitors may potentially trigger palmoplantar pustulosis in patients with a family history (genetic factor) of the condition.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf069","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:29:43Z","timestamp":1762777783000},"source":"Crossref","is-referenced-by-count":1,"title":["A patient with certolizumab pegol-induced palmoplantar pustulosis or pustulotic arthro-osteitis: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3663-0797","authenticated-orcid":false,"given":"Ayaka","family":"Hane","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oba","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigekazu","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kishi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takazawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Okinaka Memorial Institute for Medical Research, Toranomon Hospital , Minato City ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2025113002114103700_ref1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/ard-2024-225914","article-title":"Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease","volume":"83","author":"Yoshimura","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025113002114103700_ref2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s13555-024-01210-3","article-title":"Certolizumab pegol for the treatment of plaque psoriasis in routine clinical practice: One-year results from the CIMREAL study","volume":"14","author":"Korge","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025113002114103700_ref3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2169\/internalmedicine.9059-21","article-title":"Endothelial damage-dominant nephritis related to IgA Vasculitis after 11 years\u2019 use of infliximab for rheumatoid arthritis","volume":"62","author":"Fukuda","year":"2023","journal-title":"Intern Med"},{"key":"2025113002114103700_ref4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2169\/internalmedicine.0858-22","article-title":"Tocilizumab attenuates anti-neutrophil cytoplasmic antibody-associated nephritis occurring during abatacept and adalimumab therapy for rheumatoid arthritis","volume":"62","author":"Yoshimura","year":"2023","journal-title":"Intern Med"},{"key":"2025113002114103700_ref5","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2011.05.038","article-title":"Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-\u03b1 inhibitors: The Mayo Clinic experience, 1998 to 2010","volume":"67","author":"Shmidt","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2025113002114103700_ref6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fphar.2019.00282","article-title":"Paradoxical skin reactions to biologics in patients with rheumatologic disorders","volume":"10","author":"Garcovich","year":"2019","journal-title":"Front Pharmacol"},{"key":"2025113002114103700_ref7","first-page":"40","article-title":"A case of palmoplantar pustulosis induced by certolizumab pegol","volume":"5","author":"Shelling","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025113002114103700_ref8","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.reuma.2017.12.004","article-title":"Certolizumab pegol-induced palmoplantar pustulosis: A case report and review of the literature","volume":"15","author":"Villalobos-S\u00e1nchez","year":"2019","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"2025113002114103700_ref9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13555-020-00398-4","article-title":"Paradoxical skin reaction to certolizumab, an overlap of pyoderma gangrenosum and psoriasis in a young woman treated for ankylosing spondylitis: Case report with literature review","volume":"10","author":"Gawdzik","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025113002114103700_ref10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/tpj.2015.53","article-title":"Paradoxical psoriasiform reactions to anti-TNF\u03b1 drugs are associated with genetic polymorphisms in patients with psoriasis","volume":"16","author":"Cabaleiro","year":"2016","journal-title":"Pharmacogenomics J"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf069\/65269189\/rxaf069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf069\/65269189\/rxaf069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf069\/65269189\/rxaf069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T07:11:48Z","timestamp":1764486708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf069\/8320489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf069","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf069"}}